Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Ponatinib, venetoclax and dexamethasone for patients with relapsed or refractory...
Dr Nicholas Short - MD Anderson Cancer Center, Houston, USA
Ponatinib, venetoclax and dexamethasone for patients with relapsed or refractory Philadelphia chromosome-positive ALL ( Dr Nicholas Short - MD Anderson Cancer Center, Houston, USA )
7 Dec 2020
Clinical implications of MRD detection in infants with KMT2A-rearranged ALL Trea...
Dr Janine Stutterheim - Princess Máxima Center, Utrecht, Netherlands
Clinical implications of MRD detection in infants with KMT2A-rearranged ALL Treated on the Interfant-06 protocol ( Dr Janine Stutterheim - Princess Máxima Center, Utrecht, Netherlands )
7 Dec 2020
Predictive factors for overall survival in chronic myeloid leukaemia patients: a...
Prof Giuseppe Saglio - A.O. Ordine Mauriziano, Turin, Italy
Predictive factors for overall survival in chronic myeloid leukaemia patients: an analysis by the Gimema CML Italian study ( Prof Giuseppe Saglio - A.O. Ordine Mauriziano, Turin, Italy )
6 Dec 2020
Cranial radiation mostly eliminated in children with T-ALL and bortezomib potent...
Prof David Teachey - The University of Pennsylvania, Rutledge, USA
Cranial radiation mostly eliminated in children with T-ALL and bortezomib potentially improves survival in children with T-LL ( Prof David Teachey - The University of Pennsylvania, Rutledge, USA )
6 Dec 2020
Ibrutinib plus venetoclax for first-line treatment of chronic lymphocytic leukae...
Dr William Wierda - University of Texas MD Anderson Cancer Center, Houston, USA
Ibrutinib plus venetoclax for first-line treatment of chronic lymphocytic leukaemia ( Dr William Wierda - University of Texas MD Anderson Cancer Center, Houston, USA )
5 Dec 2020
ecancer special issue on immunotherapy
Dr Nicola Fusco and Elham Sajjadi - European Institute of Oncology, Milan, Italy
ecancer special issue on immunotherapy ( Dr Nicola Fusco and Elham Sajjadi - European Institute of Oncology, Milan, Italy )
3 Dec 2020
PARP inhibitors in prostate cancer: A promise delivered
Dr Abhishek Tripathi - Stephenson Cancer Center, Oklahoma City, USA
PARP inhibitors in prostate cancer: A promise delivered ( Dr Abhishek Tripathi - Stephenson Cancer Center, Oklahoma City, USA )
1 Dec 2020
SIOG 2020 Annual Meeting global message and continuity with SIOG 2021
Prof Holly Holmes and Prof Kwok-Leung Cheung
SIOG 2020 Annual Meeting global message and continuity with SIOG 2021 ( Prof Holly Holmes and Prof Kwok-Leung Cheung )
27 Nov 2020
Targeting a KRAS neoantigen peptide vaccine to DNGR-1 dendritic cells
Dr Rachel Ambler - The Francis Crick Institute, London, United Kingdom
Targeting a KRAS neoantigen peptide vaccine to DNGR-1  dendritic cells ( Dr Rachel Ambler - The Francis Crick Institute, London, United Kingdom )
27 Nov 2020
OncoAlert and ecancer weekly roundup for November 15 - 21, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for November 15 - 21, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
27 Nov 2020
Updates in geriatric oncology from SIOG 2020
Dr Siri Rostoft - Oslo University Hospital, Oslo, Norway
Updates in geriatric oncology from SIOG 2020 ( Dr Siri Rostoft - Oslo University Hospital, Oslo, Norway )
25 Nov 2020
SIOG 2020: Prostate cancer and how COVID is impacting the treatment of elderly p...
Prof Nicolas Mottet and Prof Matti Aapro
SIOG 2020: Prostate cancer and how COVID is impacting the treatment of elderly patients ( Prof Nicolas Mottet and Prof Matti Aapro )
25 Nov 2020